BeStock  
Stocks › AVTX

Avalo Therapeutics AVTX

US equityMarket cap rank #3479
$13.58 −$0.01 (-0.07%)
Pre-market · Oct 8, 8:20 am ET · After hours $13.58 0.00%
Open$13.43
Prev close$13.59
Day range$13.30 – $13.98
Volume719.0K
Market cap$728.30M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$31.52M-63.2% YoY
Net profit-$36.36M-75.1% YoY
Diluted EPS-$0.83+56.8% YoY
Free cash flow-$19.99M-75.5% YoY
Operating cash flow-$19.99M

Revenue, last 8 quarters

$249.0KSep '24$192.0KDec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$59.0KDec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$23.0MSep '24$-35.3MDec '24$-13.1MMar '25$-20.8MJun '25$-30.6MSep '25$-13.7MDec '25$-19.6MMar '26$-36.4MJun '26

Diluted EPS by quarter

-2.83Sep '24-3.36Dec '24-1.25Mar '25-1.92Jun '25-2.19Sep '25-0.37Dec '25-0.98Mar '26-0.83Jun '26

Free cash flow by quarter

$-11.5MSep '24$-15.0MDec '24$-9.5MMar '25$-11.4MJun '25$-16.4MSep '25$-14.2MDec '25$-17.7MMar '26$-20.0MJun '26

Annual revenue

$6.7MFY20$5.4MFY21$18.1MFY22$1.9MFY23$441.0KFY24$59.0KFY25

Profitability & balance sheet

Operating margin-154,847.5%
Net margin-170,055.9%
Return on equity-36.3%
Return on assets-32.5%
Return on invested capital-36.2%
Current ratio19.31
Liabilities / assets8.6%
Cash & investments$400.28M
Total debt$0.00
Net cash (debt)$400.28M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Operating Revenue $0.00 $0.00 $59,000.00 $59,000.00 $0.00
Operating Expense $31.52M $20.90M $72.98M $19.80M $19.20M
Selling and Admin Expenses $8.10M $6.85M $22.90M $6.53M $5.58M
-Selling & Marketing Expense $126,000.00 $209,000.00 $470,000.00 $381,000.00 $22,000.00
-General & Admin Expense $7.97M $6.65M $22.43M $6.15M $5.56M
Research & Development $23.42M $14.05M $50.08M $13.27M $13.62M
Operating Profit -$31.52M -$20.90M -$72.93M -$19.74M -$19.20M
Net Non-Operating Interest Income (Expense) $2.76M $803,000.00 $4.35M $984,000.00 $1.12M
Non-Operating Interest Income $2.76M $803,000.00 – – $1.12M
Other Income (Expense) -$7.58M $480,000.00 -$9.52M $5.17M -$12.53M
Gain on Sale of Security -$1.01M $480,000.00 -$9.52M $5.16M -$12.53M
Special Income (Charges) -$6.57M – $0.00 $0.00 $0.00
-Less:Restructuring and Mergern & Acquisition $6.57M – $0.00 – –
Pretax Profit -$36.34M -$19.62M -$78.09M -$13.59M -$30.61M
Tax $18,000.00 $12,000.00 $165,000.00 $130,000.00 $11,000.00
Net Profit -$36.36M -$19.63M -$78.26M -$13.72M -$30.63M
Profit from Continuing Operations -$36.36M -$19.63M -$78.26M -$13.72M -$30.63M
Net Income to Parent Company -$36.36M -$19.63M -$78.26M -$13.72M -$30.63M
Net Income to Common Stockholders -$36.36M -$19.63M -$78.26M -$13.72M -$30.63M
Basic EPS -$0.83 -$0.98 -$5.84 -$0.37 -$2.19
Diluted EPS -$0.83 -$0.98 -$5.84 -$0.37 -$2.19
Total Revenue as Reported – – $59,000.00 $59,000.00 $0.00
Cost of Revenue – – $0.00 $0.00 $0.00
Gross Profit – – $59,000.00 $59,000.00 $0.00
Total Other Finance Costs – – -$4.35M – –
Other Non-Operating Income (Expenses) – – – – -$3,000.00

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $490.78M $99.89M $116.46M $116.46M $125.10M
Total Current Assets $407.93M $88.83M $105.29M $105.29M $113.85M
Cash and Cash Equivalents & Short-Term Investments $400.28M $81.99M $98.34M $98.34M $111.62M
-Cash and Cash Equivalents $85.38M $24.99M $15.86M $15.86M $26.96M
-Short Term Investments $314.89M $57.01M $82.48M $82.48M $84.65M
Restricted Cash $49,000.00 $147,000.00 $37,000.00 $37,000.00 $90,000.00
Other Current Assets $7.61M $6.69M $6.91M $6.91M $2.14M
Total Non-Current Assets $82.85M $11.06M $11.17M $11.17M $11.25M
Net PPE $288,000.00 $375,000.00 $460,000.00 $460,000.00 $542,000.00
Investments and Advances $71.88M – – – –
Goodwill and Other Intangible Assets $10.50M $10.50M $10.50M $10.50M $10.50M
-Goodwill $10.50M $10.50M $10.50M $10.50M $10.50M
Other Non-Current Assets $183,000.00 $183,000.00 $210,000.00 $210,000.00 $210,000.00
Total Liabilities $42.12M $31.57M $33.41M $33.41M $33.55M
Total Current Liabilities $21.13M $11.60M $12.94M $12.94M $7.97M
Payables $3.35M $683,000.00 $464,000.00 $464,000.00 $801,000.00
-Accounts Payable $3.35M $356,000.00 $137,000.00 $137,000.00 $474,000.00
Current Accrued Expenses $14.74M $8.84M $7.95M $7.95M $3.35M
Short-Term Debt and Capital Lease Obligation $242,000.00 $328,000.00 $392,000.00 $392,000.00 $438,000.00
-Current Capital Lease Obligation $242,000.00 $328,000.00 $392,000.00 $392,000.00 $438,000.00
Total Non-Current Liabilities $20.99M $19.97M $20.47M $20.47M $25.58M
Long Term Debt and Capital Lease Obligation $0.00 $0.00 – – $117,000.00
-Long Term Capital Lease Obligation $0.00 $0.00 – – $117,000.00
Derivative Product Liabilities $18.53M $17.52M $18.00M $18.00M $23.16M
Non-Current Deferred Liabilities $463,000.00 $446,000.00 $434,000.00 $434,000.00 $304,000.00
Convertible preferred securities $0.00 $0.00 $0.00 $0.00 $0.00
Other Non-Current Liabilities $2.00M $2.00M $2.04M $2.04M $2.00M
Total Equity $448.66M $68.32M $83.05M $83.05M $91.55M
Stockholders' Equity $448.66M $68.32M $83.05M $83.05M $91.55M
Capital Stock $53,000.00 $25,000.00 $18,000.00 $18,000.00 $18,000.00
-Common Stock $53,000.00 $25,000.00 $18,000.00 $18,000.00 $18,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $953.70M $536.45M $531.49M $531.49M $526.29M
Retained Earnings -$504.51M -$468.15M -$448.52M -$448.52M -$434.80M
Gains/Losses Not Affecting Retained Earnings -$583,000.00 -$6,000.00 $68,000.00 $68,000.00 $41,000.00
-Other Payable – $327,000.00 $327,000.00 $327,000.00 $327,000.00
-Gross PPE – – $713,000.00 $713,000.00 –
-Accumulated Depreciation – – -$253,000.00 -$253,000.00 –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$19.99M -$17.69M -$51.46M -$14.25M -$16.37M
Net cash flow from continuing operations -$19.99M -$17.69M -$51.46M -$14.25M -$16.37M
Net Income from Continuing Operations -$36.36M -$19.63M -$78.26M -$13.72M -$30.63M
Gain/Loss from Continuing Operations $1.01M -$480,000.00 $9.52M -$5.16M $12.53M
Depreciation & Depletion & Amortization $17,000.00 $17,000.00 $344,000.00 $16,000.00 $59,000.00
Deferred Tax $17,000.00 $12,000.00 $165,000.00 $131,000.00 $10,000.00
Other Non-Cash Items $1.87M -$106,000.00 -$690,000.00 – –
Change in Working Capital $8.68M -$1.08M $3.84M $176,000.00 -$1.15M
-Change in Prepaid Assets -$922,000.00 $228,000.00 -$2.59M -$4.77M -$236,000.00
-Change in Payables and Accrued Expense $9.62M -$1.28M $6.52M $5.01M -$872,000.00
-Change in Other Current Liabilities -$16,000.00 -$31,000.00 -$87,000.00 -$63,000.00 -$38,000.00
Net cash flow from investing -$329.93M $25.51M -$81.72M $2.40M -$13.26M
Net Cash Flow from Continuing Investing Activities -$329.93M $25.51M -$81.72M $2.40M -$13.26M
Net Investment Purchase and Sale -$329.93M $25.51M -$81.72M $2.40M -$13.26M
Financing Cash Flow $410.21M $1.40M $14.59M $687,000.00 $14.37M
Net Cash Flow from Continuing Financing Activities $410.21M $1.40M $14.59M $687,000.00 $14.37M
Proceeds from Stock Option Exercised $5.30M $2.18M $797,000.00 $757,000.00 $0.00
Net Other Financing Charges -$26.40M -$779,000.00 -$972,000.00 -$462,000.00 -$1,000.00
Ending Cash Balance $85.61M $25.32M $16.11M $16.11M $27.26M
Net Change in Cash $60.30M $9.21M -$118.59M -$11.16M -$15.26M
Beginning Cash Balance $25.32M $16.11M $134.70M $27.26M $42.52M
Free Cash Flow -$19.99M -$17.69M -$51.46M -$14.25M -$16.37M
-Change in Receivables – – $0.00 – –
Net Business Purchase and Sale – – $0.00 $0.00 –
Net Common Stock Issuance – – $14.76M $392,000.00 $14.37M

Discussion

No comments yet — be the first to weigh in on AVTX.

Leave a comment

Scroll to Top